Savior Lifetec Corporation (TPEX:4167)

Market Cap	6.44B
Revenue (ttm)	1.22B
Net Income (ttm)	497.38M
Shares Out	317.40M
EPS (ttm)	1.56
PE Ratio	13.01
Forward PE	n/a
Dividend	0.09 (0.43%)
Ex-Dividend Date	n/a

Volume	358,214
Average Volume	1,137,976
Open	20.35
Previous Close	20.30
Day's Range	20.25 - 20.45
52-Week Range	14.35 - 27.80
Beta	0.28
RSI	45.75
Earnings Date	Aug 8, 2025

About Savior Lifetec

Savior Lifetec Corporation, a specialty injectable company, develops, produces, and supplies sterile active pharmaceutical ingredients and finished dosage formulations. The company provides various carbapenem generic drugs and injections, such as paliperidone palmitate, cetrorelix and ganirelix acetate, plecanatide, prucalopride succinate, and brinzolamide. It offers imipenem and cilastatin, meropenem, and ertapenem products. The company was founded in 1993 and is headquartered in Miaoli County, Taiwan.

• Industry: Biotechnology
• Sector: Healthcare
• Founded: 1993
• Employees: 384
• Stock Exchange: Taipei Exchange
• Ticker Symbol: 4167

Financial Performance

In 2024, Savior Lifetec's revenue was 1.22 billion, an increase of 15.91% compared to the previous year's 1.05 billion. Earnings were 182.38 million, an increase of 507.33%.